Drug intelligence / Profile preview

polyethylene glycol + lactulose

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

Polyethylene glycol (PEG) combined with lactulose is a combination therapy used primarily for bowel preparation before colonoscopy and for the treatment of constipation, particularly in patients with chronic constipation. This combination has shown better efficacy than PEG alone in bowel cleansing, with fewer adverse reactions such as abdominal pain, nausea, and vomiting. The combination is also used in the management of hepatic encephalopathy, where it has demonstrated improved outcomes compared to lactulose alone. The mechanism of action combines the effects of both medications: - Polyethylene glycol works as an osmotic laxative by binding water in the intestinal lumen, increasing stool volume and stimulating bowel movements. - Lactulose is a non-absorbable sugar that is metabolized by colonic bacteria to produce organic acids, which acidify the colon contents, drawing water into the bowel and stimulating peristalsis. In hepatic encephalopathy, lactulose also helps trap ammonia in the colon by converting it to non-absorbable ammonium ions, reducing blood ammonia levels.

Other names
PEG + lactulose
02

Targets

Colonic lumen water/osmotic gradient

Beyond the preview

Go deeper on polyethylene glycol + lactulose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol + lactulose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call